Subjects

Abstract

Vascularization is essential for tissue development and in restoration of tissue integrity after an ischemic injury. In studies of vascularization, the focus has largely been placed on vascular endothelial growth factor (VEGF), yet other factors may also orchestrate this process. Here we show that succinate accumulates in the hypoxic retina of rodents and, via its cognate receptor G protein–coupled receptor-91 (GPR91), is a potent mediator of vessel growth in the settings of both normal retinal development and proliferative ischemic retinopathy. The effects of GPR91 are mediated by retinal ganglion neurons (RGCs), which, in response to increased succinate levels, regulate the production of numerous angiogenic factors including VEGF. Accordingly, succinate did not have proangiogenic effects in RGC-deficient rats. Our observations show a pathway of metabolite signaling where succinate, acting through GPR91, governs retinal angiogenesis and show the propensity of RGCs to act as sensors of ischemic stress. These findings provide a new therapeutic target for modulating revascularization.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , & Growth regulation of the vascular system: evidence for a metabolic hypothesis. Am. J. Physiol. 259, R393–R404 (1990).

  2. 2.

    Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies. Ophthalmic Res. 29, 354–362 (1997).

  3. 3.

    et al. Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy. EMBO J. 21, 4307–4316 (2002).

  4. 4.

    et al. Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 276, 1706–1709 (1997).

  5. 5.

    et al. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N. Engl. J. Med. 353, 782–792 (2005).

  6. 6.

    Mechanisms of retinal and choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 35, 3974–3979 (1994).

  7. 7.

    , , , & Mechanisms of hepatocyte growth factor–induced retinal endothelial cell migration and growth. Invest. Ophthalmol. Vis. Sci. 41, 1885–1893 (2000).

  8. 8.

    , , & Influence of complete ischemia on glycolytic metabolites, citric acid cycle intermediates, and associated amino acids in the rat cerebral cortex. Brain Res. 80, 265–279 (1974).

  9. 9.

    & Ischemia and aging brain. Studies on glucose and energy metabolism in rat cerebral cortex. Neurobiol. Aging 7, 23–29 (1986).

  10. 10.

    , , , & Modulation of the flavin redox potential as mode of regulation of succinate dehydrogenase activity. Biochim. Biophys. Acta 591, 400–408 (1980).

  11. 11.

    , , , & Presence and regulation of the α-ketoglutarate dehydrogenase multienzyme complex in the filamentous fungus Aspergillus niger. J. Bacteriol. 161, 265–271 (1985).

  12. 12.

    et al. The tricarboxylic acid cycle, an ancient metabolic network with a novel twist. PLoS ONE 2, e690 (2007).

  13. 13.

    & Angiogenesis mediated by metabolites is dependent on vascular endothelial growth factor (VEGF). Angiogenesis 6, 73–77 (2003).

  14. 14.

    et al. Angiogenic activity of pyruvic acid in in vivo and in vitro angiogenesis models. Cancer Res. 61, 3290–3293 (2001).

  15. 15.

    & A study of metabolites as intermediate effectors in angiogenesis. Angiogenesis 4, 71–77 (2001).

  16. 16.

    & Growth-promoting properties of pyruvate oxal-acetate, and α-ketoglutarate for isolated Walker carcinosarcoma 256 cells. Proc. Soc. Exp. Biol. Med. 98, 303–306 (1958).

  17. 17.

    et al. Citric acid cycle intermediates as ligands for orphan G protein–coupled receptors. Nature 429, 188–193 (2004).

  18. 18.

    et al. Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy. Circulation 108, 198–204 (2003).

  19. 19.

    , , , & Analysis of dicarboxylic acids by tandem mass spectrometry. High-throughput quantitative measurement of methylmalonic acid in serum, plasma, and urine. Clin. Chem. 47, 1993–2002 (2001).

  20. 20.

    , , , & Delivery of ciliary neurotrophic factor via lentiviral-mediated transfer protects axotomized retinal ganglion cells for an extended period of time. Hum. Gene Ther. 14, 103–115 (2003).

  21. 21.

    et al. GPR99, a new G protein–coupled receptor with homology to a new subgroup of nucleotide receptors. BMC Genomics 3, 17 (2002).

  22. 22.

    et al. Neuronal VEGF expression correlates with angiogenesis in postnatal developing rat brain. Brain Res. Dev. Brain. Res. 119, 139–153 (2000).

  23. 23.

    & Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc. Natl. Acad. Sci. USA 95, 15809–15814 (1998).

  24. 24.

    et al. VEGF protein associates to neurons in remote regions following cortical infarct. J. Cereb. Blood Flow Metab. 27, 76–85 (2007).

  25. 25.

    , , , & Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors. Proc. Natl. Acad. Sci. USA 98, 4160–4165 (2001).

  26. 26.

    , , & Effect of anti-VEGF antibody on retinal ganglion cells in rats. Br. J. Ophthalmol. 91, 1230–1233 (2007).

  27. 27.

    et al. Proangiogenic effects of protease-activated receptor 2 are tumor necrosis factor-α and consecutively Tie2 dependent. Arterioscler. Thromb. Vasc. Biol. 26, 744–750 (2006).

  28. 28.

    & Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp. Cell Res. 312, 630–641 (2006).

  29. 29.

    et al. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J. Biol. Chem. 282, 4524–4532 (2007).

  30. 30.

    et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell 7, 77–85 (2005).

  31. 31.

    , & VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP. Mol. Vis. 10, 512–520 (2004).

  32. 32.

    , , , & Expression of vascular endothelial growth factor isoforms and their receptors Flt-1, KDR and neuropilin-1 in synovial tissues of rheumatoid arthritis. J. Pathol. 191, 426–433 (2000).

  33. 33.

    et al. VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2. Invest. Ophthalmol. Vis. Sci. 45, 368–374 (2004).

  34. 34.

    , , , & Fibroblast growth factor-2 gene delivery stimulates axon growth by adult retinal ganglion cells after acute optic nerve injury. Mol. Cell. Neurosci. 24, 656–672 (2003).

  35. 35.

    , , , & Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J. Neurosci. 14, 4368–4374 (1994).

  36. 36.

    , , & Glial reactivity in the retina of adult rats. Glia 15, 105–118 (1995).

  37. 37.

    et al. Ganglion cells are required for normal progenitor cell proliferation but not cell-fate determination or patterning in the developing mouse retina. Curr. Biol. 15, 525–530 (2005).

  38. 38.

    et al. Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy. Curr. Eye Res. 18, 20–27 (1999).

  39. 39.

    & Retinal angiogenesis in development and disease. Nature 438, 960–966 (2005).

  40. 40.

    & Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors. Exp. Eye Res. 83, 473–483 (2006).

  41. 41.

    , , & Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843–845 (1992).

  42. 42.

    & The control of tricarboxylate-cycle oxidations in blowfly flight muscle. The steady-state concentrations of citrate, isocitrate 2-oxoglutarate and malate in flight muscle and isolated mitochondria. Biochem. J. 146, 527–535 (1975).

  43. 43.

    & Effects of ischaemia on content of metabolites in rat liver and kidney in vivo. Biochem. J. 120, 105–111 (1970).

  44. 44.

    , , , & Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. USA 92, 905–909 (1995).

  45. 45.

    et al. Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 35, 101–111 (1994).

  46. 46.

    , , , & Isolated capillary proliferation in Leigh's syndrome. Clin. Neuropathol. 13, 139–141 (1994).

  47. 47.

    , , & Clinico-neuropathological study of a Chinese case of familial adult Leigh syndrome. Neuropathology 26, 218–221 (2006).

  48. 48.

    & Comparative anatomy of the vascular supply of the eye in vertebrates. in In The Eye Vol. 5, (ed. H. Davson & L.T. Graham) 1–70 (Academic Press, New York, 1974).

  49. 49.

    Ophthalmoscopic studies on the eyes of mammals. Phil. Trans. R. Soc. Lond. B2, 1–82 (1968).

  50. 50.

    Retinal Circulation in Man and Mammals. (ed. Thomas, C.C.) Ch. 1–9 (Charles C. Thomas, Springfield, Illinois, 1954).

  51. 51.

    , & Oxygen consumption in the inner and outer retina of the cat. Invest. Ophthalmol. Vis. Sci. 36, 542–554 (1995).

  52. 52.

    et al. PDGF mediates a neuron-astrocyte interaction in the developing retina. Neuron 17, 1117–1131 (1996).

  53. 53.

    , & Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis. Invest. Ophthalmol. Vis. Sci. 41, 1217–1228 (2000).

  54. 54.

    & Development of the retinofugal pathway in birds and mammals: evidence for a common 'timetable'. Brain Behav. Evol. 31, 369–390 (1988).

  55. 55.

    , , & Oxygen distribution and consumption in the developing rat retina. Invest. Ophthalmol. Vis. Sci. 47, 4072–4076 (2006).

  56. 56.

    et al. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α. Nature 451, 1008–1012 (2008).

  57. 57.

    et al. Kinase-dependent differentiation of a retinal ganglion cell precursor. Invest. Ophthalmol. Vis. Sci. 47, 427–438 (2006).

  58. 58.

    et al. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463–8471 (1998).

  59. 59.

    , & Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat. Pediatr. Res. 36, 724–731 (1994).

Download references

Acknowledgements

This work was supported by grants from the Canadian Institutes of Health Research, the March of Dimes Birth Defects Foundation, the Heart and Stroke Foundation of Québec and the Fonds de la Recherche en Santé du Québec. P.S. and M.S. hold a Research Fellowship Award and a studentship from the Heart and Stroke Foundation of Canada, respectively. K.Z. is a recipient of The Foundation Fighting Blindness Postdoctoral Fellowship Award. F.S. and S.C. are recipients of a fellowship and scientist awards, respectively, from the Canadian Institutes of Health Research. S.C. also holds a Canada Research Chair (perinatology). Generation of brn3bZ-dta/+;six3-cre mice and J.-H.C.'s salary were supported by a US National Eye Institute grant EY011930 to W.H.K. and by the Robert A. Welch Foundation (G-0010), respectively. We wish to thank N. Agarwal, from the University of North Texas Health Science Center at Fort Worth, for his kind donation of the RGC-5 cell line. We also wish to thank H. Fernandez and S. Leclerc for valuable technical assistance.

Author information

Author notes

    • Przemyslaw Sapieha
    •  & Mirna Sirinyan

    These authors contributed equally to this work.

Affiliations

  1. Research Center of Centre Hospitalier Universitaire Sainte-Justine, Departments of Pediatrics and Pharmacology, Université de Montréal, Montreal, Quebec H3T 1C5, Canada.

    • Przemyslaw Sapieha
    • , Mirna Sirinyan
    • , David Hamel
    • , Karine Zaniolo
    • , Jean-Sébastien Joyal
    • , Jean-Claude Honoré
    • , Sophie Tremblay
    • , Martin Leduc
    • , Lenka Rihakova
    • , Pierre Hardy
    • , Christian Beauséjour
    • , Gregor Andelfinger
    • , Grant Mitchell
    •  & Sylvain Chemtob
  2. Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec H3G 1Y6, Canada.

    • Przemyslaw Sapieha
    • , Mirna Sirinyan
    • , Jean-Sébastien Joyal
    •  & Daya R Varma
  3. Department of Biochemistry and Molecular Biology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

    • Jang-Hyeon Cho
    • , William H Klein
    •  & Xiuqian Mu
  4. Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche Scientique S 872, Centre de Recherche des Cordeliers, F-75006 Paris, France.

    • Elsa Kermorvant-Duchemin
    •  & Florian Sennlaub
  5. Mass Spectrometry Facility, Department of Medicine, McGill University Montreal, Quebec H3A 1A4, Canada.

    • Orval Mamer
  6. Departments of Ophthalmology and Neurology-Neurosurgery, McGill University-Montreal Children's Hospital Research Institute, Montreal, Quebec H3H 1P3, Canada.

    • Pierre Lachapelle
  7. Department of Pathology and Cell Biology, University of Montreal, Montreal, Quebec H3T 1J4, Canada.

    • Adriana Di Polo
  8. Université Pierre et Marie Curie (Paris 6), Unité Mixte de Recherche Scientique S 872, F-75006 Paris, France.

    • Florian Sennlaub
  9. Université Paris Descartes, Unité Mixte de Recherche Scientique 872, F-75006 Paris, France.

    • Florian Sennlaub

Authors

  1. Search for Przemyslaw Sapieha in:

  2. Search for Mirna Sirinyan in:

  3. Search for David Hamel in:

  4. Search for Karine Zaniolo in:

  5. Search for Jean-Sébastien Joyal in:

  6. Search for Jang-Hyeon Cho in:

  7. Search for Jean-Claude Honoré in:

  8. Search for Elsa Kermorvant-Duchemin in:

  9. Search for Daya R Varma in:

  10. Search for Sophie Tremblay in:

  11. Search for Martin Leduc in:

  12. Search for Lenka Rihakova in:

  13. Search for Pierre Hardy in:

  14. Search for William H Klein in:

  15. Search for Xiuqian Mu in:

  16. Search for Orval Mamer in:

  17. Search for Pierre Lachapelle in:

  18. Search for Adriana Di Polo in:

  19. Search for Christian Beauséjour in:

  20. Search for Gregor Andelfinger in:

  21. Search for Grant Mitchell in:

  22. Search for Florian Sennlaub in:

  23. Search for Sylvain Chemtob in:

Corresponding author

Correspondence to Sylvain Chemtob.

Supplementary information

PDF files

  1. 1.

    Supplementary Text and Figures

    Supplementary Figs. 1-4, Supplementary Table 1 and Supplementary Methods

Videos

  1. 1.

    Supplementary Video 1

    Three-dimensional confocal representation of a 30-μm–thick radial section of the retina. GPR91-positive cells are labeled in green, whereas lectin-stained blood vessels are in red. A lack of overlap indicates that GPR91 is not expressed in retinal blood vessels.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nm.1873

Further reading